Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse

Dhaval Dave, Anca M. Grecu and Henry Saffer ()

No 23537, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: Despite the significant cost of prescription (Rx) drug abuse and calls from policy makers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs which is a key policy targeting the non-medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory-access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18-24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs, and find a complementary reduction in admissions related to cocaine and marijuana abuse.

JEL-codes: H0 I1 K0 (search for similar items in EconPapers)
Date: 2017-06
New Economics Papers: this item is included in nep-hea and nep-law
Note: EH
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (19)

Published as Anca M. Grecu & Dhaval M. Dave & Henry Saffer, 2019. "Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(1), pages 181-209, January.

Downloads: (external link)
http://www.nber.org/papers/w23537.pdf (application/pdf)

Related works:
Journal Article: Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse (2019)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:23537

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w23537

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().